Cureus Ocular Complications in Patients on Highly Active

Our article aims to report the ocular adverse effects of highly active antiretroviral therapy (HAART). In case 1, a 26-year-old male patient presented with a diminution of vision. In the absence of active cytomegalovirus (CMV) retinitis and a surge in CD4 count of more than 100 cells/µL over four months, he was diagnosed as a case of immune recovery uveitis (IRU). He responded well to topical steroids and cycloplegics. In case 2, while dry eye is a common adverse effect of HAART, our 53-year-old female patient progressed to a visually distressing stage of keratoconjunctivitis sicca. She responded to lubricants and continues to be on the same. In case 3, a 14-year-old female patient’s vision succumbed to Stevens-Johnson syndrome due to nevirapine in the absence of timely intervention. Though uncommon, debilitating ocular adverse effects may be seen with HAART. Further studies and reporting are required for an increased awareness among physicians and patients.

Neurologic complications of coronavirus infections

Vision, Free Full-Text

Viruses, Free Full-Text

Neurologic manifestations in hospitalized patients with COVID-19

Cureus, Ocular Tuberculosis Without a Lung Primary

Conjunctiva: Anatomy, Function, and Conditions

Cervical Vertigo and Cervicogenic Dizziness – Neck pain and dizziness – Caring Medical Florida

Frontiers Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications

Advances in Therapies and Imaging for Systemic Vasculitis

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes

Ocular Manifestations of Stevens-Johnson Syndrome

Herpes zoster ophthalmicus: a clinician's perspective

Chronic kidney disease: Symptoms, stage, treatment, and more